Miglustat

ATC A16AX06 · 7 markets · 34 records

Miglustat 7 markets · 34 records Forms

US 7 records · 2 strengths

GB 7 records · 2 strengths

ES 6 records · 2 strengths

EU 5 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 MIGLUSTAT DIPHARMA、MIGLUSTAT GEN.ORPH、OPFOLDA、Yargesa、Zavesca +2

    AU 4 records · 3 strengths

    • 100 mgcapsuleZAVESCA miglustat 100 mg capsules blister pack also in US·GB·ES +2 unknown
    • 65 mgcapsuleOPFOLDA miglustat 65 mg capsule bottle also in US·GB·ES +1 unknown

    Records without a stated strength · 1 OPFOLDA、Zavesca

    CA 3 records · 2 strengths

    • 100 mgcapsuleSANDOZ MIGLUSTATZavesca also in US·GB·ES +2
    • 65 mgcapsuleOPFOLDA also in US·GB·ES +1

    TW 1 records · 1 strengths

    Side-by-side table

    Easily confused with:Migalastat(Migalastat migALAstat) FDA recommends tall-man lettering for this pair; check the ingredient, not the name. All pairs
    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.